-
EP2496580
European procedure
Extract from the Register of European Patents
EP About this file: EP2496580
| EP2496580 - BENZODIAZEPINE BROMODOMAIN INHIBITOR [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.10.2014 Database last updated on 26.04.2025 | Most recent event Tooltip | 24.04.2015 | Change - lapse in a contracting state State(s) deleted from list of lapses: RO | published on 27.05.2015 [2015/22] | Applicant(s) | For all designated states GlaxoSmithKline LLC Corporation Service Company 2711 Centreville Road Suite 400 Wilmington, Delaware 19808 / US | [N/P] |
| Former [2014/03] | For all designated states GlaxoSmithKline LLC Corporation Service Company 2711 Centreville Road Suite 400 Wilmington, Delaware 19808 / US | ||
| Former [2012/37] | For all designated states GlaxoSmithKline LLC One Franklin Plaza 200 North 16th Street Philadelphia, PA 19102 / US | Inventor(s) | 01 /
GOSMINI, Romain Luc Marie c/o Laboratoire GlaxoSmithKline Centre de Recherches Z.A. de Courtboeuf 25 Avenue du Quebec F-91940 Les Ulis / FR | 02 /
MIRGUET, Olivier Laboratoire GlaxoSmithKline Centre de Recherches Z.A. de Courtaboeuf 25 Avenue du Quebec F-91940 Les Ulis / FR | [2012/37] | Representative(s) | Shore, Andrew David GlaxoSmithKline Global Patents (CN925.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB | [N/P] |
| Former [2012/37] | Shore, Andrew David GlaxoSmithKline Corporate Intellectual Property (CN 925.1) 980 Great West Road Brentford Middlesex TW8 9GS / GB | Application number, filing date | 10740654.8 | 06.08.2010 | WO2010EP61518 | Priority number, date | GB20090019433 | 05.11.2009 Original published format: GB 0919433 | GB20100010509 | 22.06.2010 Original published format: GB 201010509 | [2012/37] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2011054553 | Date: | 12.05.2011 | Language: | EN | [2011/19] | Type: | A1 Application with search report | No.: | EP2496580 | Date: | 12.09.2012 | Language: | EN | The application published by WIPO in one of the EPO official languages on 12.05.2011 takes the place of the publication of the European patent application. | [2012/37] | Type: | B1 Patent specification | No.: | EP2496580 | Date: | 11.12.2013 | Language: | EN | [2013/50] | Search report(s) | International search report - published on: | EP | 12.05.2011 | Classification | IPC: | C07D487/04, A61K31/55, A61P35/00, A61P43/00 | [2012/37] | CPC: |
C07D487/04 (EP,KR,US);
A61K31/551 (EP,US);
A61K31/5517 (EP,KR,US);
A61K45/06 (US);
A61P29/00 (EP);
A61P35/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P43/00 (EP);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2012/37] | Extension states | BA | 27.04.2012 | ME | 27.04.2012 | RS | 27.04.2012 | Title | German: | BENZODIAZEPIN-BROMDÖMÄNENHEMMER | [2012/37] | English: | BENZODIAZEPINE BROMODOMAIN INHIBITOR | [2012/37] | French: | INHIBITEUR DE BROMODOMAINE DE BENZODIAZÉPINE | [2012/37] | Entry into regional phase | 27.04.2012 | National basic fee paid | 27.04.2012 | Designation fee(s) paid | 27.04.2012 | Examination fee paid | Examination procedure | 27.04.2012 | Amendment by applicant (claims and/or description) | 27.04.2012 | Examination requested [2012/37] | 24.04.2013 | Communication of intention to grant the patent | 16.07.2013 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 02.08.2013 | Communication of intention to grant the patent | 28.10.2013 | Fee for grant paid | 28.10.2013 | Fee for publishing/printing paid | Divisional application(s) | EP13192666.9 / EP2722334 | EP16150637.3 / EP3037423 | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 24.04.2013 | Opposition(s) | 12.09.2014 | No opposition filed within time limit [2014/47] | Fees paid | Renewal fee | 08.08.2012 | Renewal fee patent year 03 | 07.08.2013 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | deleted | [2015/22] |
| Former [2014/37] | RO | 11.12.2013 | Cited in | International search | [Y]US5116971 (HARREUS ALBRECHT [DE], et al); | [X]EP0934940 (JAPAN TOBACCO INC [JP]); | [YD]WO2009084693 (MITSUBISHI TANABE PHARMA CORP [JP], et al) | by applicant | GB2242134 | WO2005044354 | JP2008156311 | WO2009084693 |